CV-6209, A HIGHLY POTENT ANTAGONIST OF PLATELET-ACTIVATING-FACTOR INVITRO AND INVIVO

被引：0
|
作者：
TERASHITA, ZI
IMURA, Y
TAKATANI, M
TSUSHIMA, S
NISHIKAWA, K
机构：
[1] TAKEDA CHEM IND LTD,DIV CENT,BIOL LABS,YODOGAWA KU,OSAKA 532,JAPAN
[2] TAKEDA CHEM IND LTD,DIV CENT,CHEM LABS,YODOGAWA KU,OSAKA 532,JAPAN
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1987年 / 242卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：263 / 268
页数：6
相关论文
共 50 条
  • [41] PREVENTION OF ENDOTOXIN-INDUCED GASTROINTESTINAL DAMAGE BY CV-3988, AN ANTAGONIST OF PLATELET-ACTIVATING-FACTOR
    WALLACE, JL
    WHITTLE, BJR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 124 (1-2) : 209 - 210
  • [42] PLATELET-ACTIVATING-FACTOR OR A PLATELET-ACTIVATING-FACTOR ANTAGONIST DECREASES TUMOR-NECROSIS-FACTOR-ALPHA IN THE PLASMA OF MICE TREATED WITH ENDOTOXIN
    FERGUSONCHANOWITZ, KM
    KATOCS, AS
    PICKETT, WC
    KAPLAN, JB
    SASS, PM
    ORONSKY, AL
    KERWAR, SS
    JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05): : 1081 - 1086
  • [43] PLATELET-ACTIVATING-FACTOR PLAYS AN IMPORTANT ROLE IN REPERFUSION INJURY IN MYOCARDIUM - EFFICACY OF PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST (CV-3988) AS COMPARED WITH LEUKOCYTE-DEPLETED REPERFUSION
    SAWA, Y
    SCHAPER, J
    ROTH, M
    NAGASAWA, K
    BALLAGI, G
    BLEESE, N
    SCHAPER, W
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 108 (05): : 953 - 959
  • [44] PLATELET-ACTIVATING-FACTOR - A POTENT CHEMOTACTIC AND CHEMOKINETIC FACTOR FOR HUMAN EOSINOPHILS
    WARDLAW, AJ
    MOQBEL, R
    CROMWELL, O
    KAY, AB
    JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06): : 1701 - 1706
  • [45] ANTAGONISTIC ACTIVITY OF ETIZOLAM ON PLATELET-ACTIVATING-FACTOR INVIVO EXPERIMENTS
    TERASAWA, M
    MIKASHIMA, H
    TAHARA, T
    MARUYAMA, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1987, 44 (04): : 381 - 386
  • [46] TRIAZOLAM IS SOMETHING ELSE - IT IS A PAF (PLATELET-ACTIVATING-FACTOR) ANTAGONIST
    ADAM, K
    OSWALD, I
    ANAESTHESIST, 1992, 41 (02): : 103 - 106
  • [47] INTERSPECIES SCALING OF A THIENODIAZEPINE PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST
    ELDER, CA
    MODI, MW
    DRUG METABOLISM AND DISPOSITION, 1995, 23 (07) : 776 - 778
  • [48] INFARCT REDUCTION BY THE PLATELET-ACTIVATING-FACTOR ANTAGONIST APAFANT IN RATS
    BIELENBERG, GW
    WAGENER, G
    BECK, T
    STROKE, 1992, 23 (01) : 98 - 103
  • [49] EFFECT OF PLATELET-ACTIVATING-FACTOR ANTAGONIST ON BRAIN INJURY IN RATS
    TOKUTOMI, T
    SIGEMORI, M
    KIKUCHI, T
    HIROHATA, M
    ACTA NEUROCHIRURGICA, 1994, : 508 - 510
  • [50] PHARMACOLOGICAL ACTIONS OF Y-24180 .1. A POTENT AND SPECIFIC ANTAGONIST OF PLATELET-ACTIVATING-FACTOR
    TERASAWA, M
    ARATANI, H
    SETOGUCHI, M
    TAHARA, T
    PROSTAGLANDINS, 1990, 40 (06): : 553 - 569
12345